These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36974677)

  • 1. An open call for nano-based therapy to address COVID-19 and oncological clinical conditions.
    Dash R; Sahoo RN; Pattnaik G; Sarangi AK; Kandi V; Mishra S; Verma S; Mohapatra RK
    Int J Surg; 2024 Apr; 110(4):2430-2432. PubMed ID: 36974677
    [No Abstract]   [Full Text] [Related]  

  • 2. Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic.
    Zuliani S; Zampiva I; Tregnago D; Casali M; Cavaliere A; Fumagalli A; Merler S; Riva ST; Rossi A; Zacchi F; Zaninotto E; Auriemma A; Pavarana M; Soldà C; Benini L; Borghesani M; Caldart A; Casalino S; Gaule M; Kadrija D; Mongillo M; Pesoni C; Biondani P; Cingarlini S; Fiorio E; Melisi D; Parolin V; Tondulli L; Belluomini L; Zecchetto C; Avesani B; Biasi A; Bovo C; Dazzani E; Dodi A; Gelmini S; Leta LC; Lo Cascio G; Lombardo F; Lucin E; Martinelli IA; Messineo L; Moscarda V; Pafumi S; Reni A; Sartori G; Scaglione IM; Shoval Y; Sposito M; Tacconelli E; Trestini I; Zambonin V; Zanelli S; Pilotto S; Milella M
    Eur J Cancer; 2020 Aug; 135():159-169. PubMed ID: 32580131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer Centers, Organizations Call for COVID-19 Vaccine for Patients With Cancer, Survivors.
    Printz C
    Cancer; 2021 Apr; 127(8):1170-1171. PubMed ID: 33878201
    [No Abstract]   [Full Text] [Related]  

  • 4. An Open Letter: COVID-19 and Cancer.
    Printz C
    Cancer; 2021 Apr; 127(8):1171. PubMed ID: 33878202
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19 in pediatric cancer patients is associated with treatment interruptions but not with short-term mortality: a Polish national study.
    Węcławek-Tompol J; Zakrzewska Z; Gryniewicz-Kwiatkowska O; Pierlejewski F; Bień E; Zaucha-Prażmo A; Zając-Spychała O; Szmydki-Baran A; Mizia-Malarz A; Bal W; Sawicka-Żukowska M; Kruk A; Ociepa T; Raciborska A; Książek A; Szczepański T; Peregud-Pogorzelski J; Krawczuk-Rybak M; Chaber R; Matysiak M; Wachowiak J; Irga-Jaworska N; Młynarski W; Dembowska-Bagińska B; Balwierz W; Matkowska-Kocjan A; Kazanowska B; Styczyński J; Ussowicz M
    J Hematol Oncol; 2021 Oct; 14(1):163. PubMed ID: 34635137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge, attitudes and practices related to the COVID-19 outbreak among Romanian adults with cancer: a cross-sectional national survey.
    Gheorghe AS; Negru ŞM; Nițipir C; Mazilu L; Marinca M; Gafton B; Ciuleanu TE; Schenker M; Dragomir RD; Gheorghe AD; Stovicek PO; Bandi-Vasilica M; Boț AC; Mihăilă RI; Zob DL; Kajanto AL; Stănculeanu DL
    ESMO Open; 2021 Feb; 6(1):100027. PubMed ID: 33399089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomedicine for the SARS-CoV-2: State-of-the-Art and Future Prospects.
    Varahachalam SP; Lahooti B; Chamaneh M; Bagchi S; Chhibber T; Morris K; Bolanos JF; Kim NY; Kaushik A
    Int J Nanomedicine; 2021; 16():539-560. PubMed ID: 33519200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vicissitudes in oncological care during COVID19.
    Shetty SS; Wollenberg B; Shabadi N; Kudpaje AS; Rao V; Merchant Y
    Oral Oncol; 2020 Aug; 107():104782. PubMed ID: 32414644
    [No Abstract]   [Full Text] [Related]  

  • 10. Does COVID-19-related cachexia mimic cancer-related cachexia? Examining mechanisms, clinical biomarkers, and potential targets for clinical management.
    Kumar NB
    J Cachexia Sarcopenia Muscle; 2021 Apr; 12(2):519-522. PubMed ID: 33554483
    [No Abstract]   [Full Text] [Related]  

  • 11. Management strategy for cancer patients in the context of the COVID-19 epidemic.
    Izmailov A; Beylerli O; Pavlov V; Gareev I; Zabelin M; Ayupov R; Musin S; Sultanbaev A
    Semin Oncol; 2020 Oct; 47(5):312-314. PubMed ID: 32811667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innovation in Cancer Care Delivery in the Era of COVID-19.
    Mullangi S; Schleicher SM; Aviki EM
    JCO Oncol Pract; 2020 Nov; 16(11):718-719. PubMed ID: 32552318
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID-19 and oncological disease.
    Šálek T; Slopovský J; Pörsök Š; Pazderová N; Mináriková Z; Zomborská E; Špánik B
    Klin Onkol; 2021; 34(3):211-219. PubMed ID: 34362259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune responses to SARS-CoV-2 in vaccinated patients receiving checkpoint blockade immunotherapy for cancer.
    Piening A; Ebert E; Khojandi N; Alspach E; Teague RM
    Front Immunol; 2022; 13():1022732. PubMed ID: 36582225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer prevales on COVID-19: To maintain high quality standard concerning diagnosis and oncological care even during a pandemic.
    Giuliani J; Bonetti A
    J Med Virol; 2021 Jan; 93(1):118-119. PubMed ID: 32779798
    [No Abstract]   [Full Text] [Related]  

  • 16. The ESMO Call to Action on COVID-19 vaccinations and patients with cancer: Vaccinate. Monitor. Educate.
    Garassino MC; Vyas M; de Vries EGE; Kanesvaran R; Giuliani R; Peters S;
    Ann Oncol; 2021 May; 32(5):579-581. PubMed ID: 33582237
    [No Abstract]   [Full Text] [Related]  

  • 17. SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry.
    Cortellini A; Tabernero J; Mukherjee U; Salazar R; Sureda A; Maluquer C; Ferrante D; Bower M; Sharkey R; Mirallas O; Plaja A; Cucurull M; Mesia R; Dalla Pria A; Newsom-Davis T; Van Hemelrijck M; Sita-Lumsden A; Apthorp E; Vincenzi B; Di Fazio GR; Tonini G; Pantano F; Bertuzzi A; Rossi S; Brunet J; Lambertini M; Pedrazzoli P; Biello F; D'Avanzo F; Lee AJX; Shawe-Taylor M; Rogers L; Murphy C; Cooper L; Andaleeb R; Khalique S; Bawany S; Ahmed S; Carmona-García MC; Fort-Culillas R; Liñan R; Zoratto F; Rizzo G; Perachino M; Doonga K; Gaidano G; Bruna R; Patriarca A; Martinez-Vila C; Pérez Criado I; Giusti R; Mazzoni F; Antonuzzo L; Santoro A; Parisi A; Queirolo P; Aujayeb A; Rimassa L; Diamantis N; Bertulli R; Fulgenzi CAM; D'Alessio A; Ruiz-Camps I; Saoudi-Gonzalez N; Garcia Illescas D; Medina I; Fox L; Gennari A; Aguilar-Company J; Pinato DJ;
    Lancet Oncol; 2023 Apr; 24(4):335-346. PubMed ID: 36898391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New models of care and multidimensional solutions for oncological patients in the post-acute SARS-COV-2 period: a "Second Phase" also for cancer patients.
    Consoli F; Cristini C; Guarinoni MG; Levaggi R; Lopomo NF; Maroldi R; Melchiori M; Motta PC; Sardini E; Berruti A; Bossi P
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11445-11454. PubMed ID: 33215472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged SARS-CoV-2 viral shedding in patients with solid tumours and associated factors.
    Rogado J; Gullón P; Obispo B; Serrano G; Lara MÁ
    Eur J Cancer; 2021 May; 148():58-60. PubMed ID: 33735810
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID 19 - Possible interrelations with respiratory comorbidities caused by occupational exposure to various hazardous bioaerosols. Part II. Clinical course, diagnostics, treatment and prevention.
    Mackiewicz B; Lemieszek MK; Dutkiewicz J
    Ann Agric Environ Med; 2021 Mar; 28(1):27-43. PubMed ID: 33775065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.